Pilot Study of CT-Based Radiomics Model for Early Evaluation of Response to Immunotherapy in Patients With Metastatic Melanoma
Objective: Determine the performance of a computed tomography (CT) -based radiomics model in predicting early response to immunotherapy in patients with metastatic melanoma.Methods: This retrospective study examined 50 patients with metastatic melanoma who received immunotherapy treatment in our hos...
Main Authors: | Zhi-long Wang, Li-li Mao, Zhi-guo Zhou, Lu Si, Hai-tao Zhu, Xi Chen, Mei-juan Zhou, Ying-shi Sun, Jun Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01524/full |
Similar Items
-
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
by: Yukinori Ozaki, et al.
Published: (2017-11-01) -
The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
by: Michael Baine, et al.
Published: (2021-01-01) -
Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma
by: Teresa Amaral, et al.
Published: (2020-04-01) -
Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T1-weighted Contrast-enhanced Imaging
by: Ying-Zhi Sun, et al.
Published: (2021-02-01) -
Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study
by: Christos Sachpekidis, et al.
Published: (2021-09-01)